Cargando…
Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
Ventilator-associated pneumonia (VAP) is the most common infectious complication in the intensive care unit. It can increase duration of mechanical ventilation, length of stay, costs, and mortality. Improvements in the administration of empirical antibiotic therapy have potential to reduce the compl...
Autores principales: | Swanson, Joseph M., Wells, Diana L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790268/ https://www.ncbi.nlm.nih.gov/pubmed/27029307 http://dx.doi.org/10.3390/antibiotics2030339 |
Ejemplares similares
-
Empiric antibiotic therapy for ventilator-associated pneumonia: a systematic review of the evidence
por: Aarts, MW, et al.
Publicado: (2003) -
Empirical Antibiotic Therapy for Gram-Negative Bacilli Ventilator-Associated Pneumonia: Observational Study and Pharmacodynamic Assessment
por: Pajot, Olivier, et al.
Publicado: (2022) -
Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022) -
Impact of the adequacy of antibiotic therapy on the outcome of ventilator-associated pneumonia
por: Goncalves-Pereira, J, et al.
Publicado: (2011) -
Challenges of Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Children
por: Rodrigues, Charlene M.C.
Publicado: (2017)